BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 19188816)

  • 1. P63 expression in gestational trophoblastic disease: correlation with proliferation and apoptotic dynamics.
    Zhang HJ; Xue WC; Siu MK; Liao XY; Ngan HY; Cheung AN
    Int J Gynecol Pathol; 2009 Mar; 28(2):172-8. PubMed ID: 19188816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis in gestational trophoblastic disease is correlated with clinical outcome and Bcl-2 expression but not Bax expression.
    Wong SY; Ngan HY; Chan CC; Cheung AN
    Mod Pathol; 1999 Nov; 12(11):1025-33. PubMed ID: 10574599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated Stat3 expression in gestational trophoblastic disease: correlation with clinicopathological parameters and apoptotic indices.
    Chan HY; Siu MK; Zhang HJ; Wong ES; Ngan HY; Chan KY; Cheung AN
    Histopathology; 2008 Aug; 53(2):139-46. PubMed ID: 18752497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Id helix-loop-helix proteins are differentially expressed in gestational trophoblastic disease.
    Xue WC; Feng HC; Chan KY; Chiu PM; Ngan HY; Khoo US; Tsao SW; Chan KW; Cheung AN
    Histopathology; 2005 Sep; 47(3):303-9. PubMed ID: 16115231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P63 expression in hydropic abortion and gestational trophoblastic diseases.
    Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
    Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles.
    Hussein MR
    Exp Mol Pathol; 2009 Aug; 87(1):63-9. PubMed ID: 19348791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p21WAF1/CIP1 expression in gestational trophoblastic disease: correlation with clinicopathological parameters, and Ki67 and p53 gene expression.
    Cheung AN; Shen DH; Khoo US; Wong LC; Ngan HY
    J Clin Pathol; 1998 Feb; 51(2):159-62. PubMed ID: 9602692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of maspin in gestational trophoblastic disease.
    Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
    Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of cell cycle proteins E2F-1, Cdk-2, Cyclin E, p27(kip1), and Ki-67 in normal placenta and gestational trophoblastic disease.
    Olvera M; Harris S; Amezcua CA; McCourty A; Rezk S; Koo C; Felix JC; Brynes RK
    Mod Pathol; 2001 Oct; 14(10):1036-42. PubMed ID: 11598175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell proliferative activity and mutation of P53 suppressor gene in human gestational trophoblastic disease.
    Persaud V; Ganjei P; Nadji M
    West Indian Med J; 1993 Dec; 42(4):142-3. PubMed ID: 7909185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of melanoma cell adhesion molecule in intermediate trophoblast.
    Shih IM; Kurman RJ
    Lab Invest; 1996 Sep; 75(3):377-88. PubMed ID: 8804361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of Ras GTPase activating protein in human trophoblastic tumors.
    Ståhle-Bäckdhal M; Inoue M; Zedenius J; Sandstedt B; DeMarco L; Flam F; Silfverswärd C; Andrade J; Friedman E
    Am J Pathol; 1995 May; 146(5):1073-8. PubMed ID: 7747802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p63 expression is useful in the distinction of epithelioid trophoblastic and placental site trophoblastic tumors by profiling trophoblastic subpopulations.
    Shih IM; Kurman RJ
    Am J Surg Pathol; 2004 Sep; 28(9):1177-83. PubMed ID: 15316317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of prostate stem cell antigen is associated with gestational trophoblastic neoplasia.
    Feng HC; Tsao SW; Ngan HY; Xue WC; Kwan HS; Siu MK; Liao XY; Wong E; Cheung AN
    Histopathology; 2008 Jan; 52(2):167-74. PubMed ID: 18184265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta.
    Vegh GL; Selcuk Tuncer Z; Fulop V; Genest DR; Mok SC; Berkowitz RS
    Gynecol Oncol; 1999 Nov; 75(2):248-53. PubMed ID: 10525381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the p53 gene and apoptosis in gestational trophoblastic disease.
    Halperin R; Peller S; Sandbank J; Bukovsky I; Schneider D
    Placenta; 2000 Jan; 21(1):58-62. PubMed ID: 10692252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HSD3B1 as a novel trophoblast-associated marker that assists in the differential diagnosis of trophoblastic tumors and tumorlike lesions.
    Mao TL; Kurman RJ; Jeng YM; Huang W; Shih IeM
    Am J Surg Pathol; 2008 Feb; 32(2):236-42. PubMed ID: 18223326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New concepts in trophoblastic growth and differentiation with practical application for the diagnosis of gestational trophoblastic disease.
    Shih IM; Kurman RJ
    Verh Dtsch Ges Pathol; 1997; 81():266-72. PubMed ID: 9474880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CDKI p27Kip1 in trophoblastic neoplasm.
    Wang G; Wang S; Wang J
    Chin Med J (Engl); 2000 Nov; 113(11):1046-8. PubMed ID: 11776123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease.
    Chilosi M; Piazzola E; Lestani M; Benedetti A; Guasparri I; Granchelli G; Aldovini D; Leonardi E; Pizzolo G; Doglioni C; Menestrina F; Mariuzzi GM
    Lab Invest; 1998 Mar; 78(3):269-76. PubMed ID: 9520940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.